查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401917

2030 年精准医疗市场预测：按产品类型、药物类型、给药途径、定序技术、技术、应用、最终用户和地区进行的全球分析

Precision Medicine Market Forecasts to 2030 - Global Analysis By Product Type, By Drug Type, Route of Administration, Sequencing Technology, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据Stratistics MRC预测，2023年全球精准医疗市场规模将达834亿美元，预计2030年将达到2023亿美元，预测期内复合年增长率为13.5%。

精准医疗考虑基因、环境和生活方式的个体差异，客製化医疗保健，帮助预防和治疗疾病。它依靠基因组定序和资料分析等先进技术，根据个人的独特特征来制定医疗决策和治疗方法。这种方法旨在透过强调个体化和有针对性的干预措施来优化疗效、最大限度地减少副作用并改善整体健康结果。

据世界卫生组织称，到本十年末，癌症发病率预计将上升 50%，癌症发病率将超过 2,000 万人。

扩大新基因组技术的使用

新兴的基因组技术越来越多地用于透过提供对个体基因组成前所未有的洞察来推进精准医学。次世代定序、基于 CRISPR 的基因编辑和先进的生物资讯学能够实现全面分析和识别与疾病相关的遗传变异。这些丰富的基因组资料有助于准确的诊断、预后和个体化治疗策略，以优化治疗结果。此外，这些技术的可近性和可负担性的提高将进一步使基因组资讯民主化，并使精准医学得到更广泛的应用。

与治疗相关的费用增加

客製化治疗通常依赖先进技术和专门药物，费用可能高得令人望而却步。这种经济负担影响了可近性并限制了这些个体化治疗的普及。此外，报销挑战和覆盖范围差异进一步阻碍了患者获得服务。

对细胞和基因治疗的需求不断增加

对细胞和基因治疗日益增长的需求代表着精准医学的重大机会。这些疗法通常根据个人的基因特征量身定制，是精准医疗个人化方法的个体化代表。生物技术的进步使得能够开发出在基因层面上解决各种疾病的创新治疗方法。随着精准医学的进步，对客製化细胞和基因疗法的需求将会增加，为研究、开发和市场扩张铺平道路。

严格的监管标准

严格的法规可能会延长核准流程并阻碍及时获得创新疗法。合规性需要严格的有效性证据，这会增加研发成本，并可能阻止小型企业和新兴企业进入市场。此外，多样化的全球监管环境使区域标准化和核准变得复杂，阻碍了精准治疗的无缝实施。

COVID-19 的影响：

COVID-19大流行加速了技术和调查方法的进步，对精准医疗市场产生了重大影响。这次大流行凸显了对个体化医疗解决方案的迫切需求，并强调了快速诊断、疫苗开发和治疗方法的重要性。此外，它还促进了全球科学界之间的合作，促进了技术创新，并促进了精准医学原理与感染疾病管理的结合。

预计在预测期内，口服细分市场将是最大的

口腔领域预计将主导精准医疗市场，因为它提供方便且患者友善的标靶治疗。这种给药方法提高了患者的依从性，并允许根据个人的遗传特征制定个体化的治疗计划。口服给药的普及将促进精准医疗的广泛采用并将其融入日常医疗保健中。此外，口服药物配方和技术的进步为医疗保健专业人员提供了提供准确有效治疗的选择，从而有助于保持该细分市场的领先地位。

药物研发领域预计在预测期内复合年增长率最高

由于人工智慧、基因组学和高通量筛检等技术进步，预计药物研发领域将在精准医学市场显着成长。这些进步将加速标靶识别、检验和药物开发，并简化客製化治疗的创建。精准医学对个体差异的关注需要强大的药物管道，从而推动该领域的投资和创新。此外，生物技术、製药公司和研究机构之间的合作正在培育新的方法，从而能够发现高度特异性的治疗方法，并且该领域预计将持续扩展。

占有率最大的地区：

北美地区占据了最大占有率，并有望主导市场。该地区拥有先进的医疗基础设施、强大的研发措施以及慢性病的高盛行率。有利的政府政策、对精准医疗的大量投资以及主要行业参与者的强大影响力奠定了北美的领导地位。此外，完善的法律规范和积极采用创新医疗技术的方法进一步增强了该地区的优势。

复合年增长率最高的地区：

由于医疗保健基础设施的快速进步和基因组学投资的增加，预计亚太地区精准医疗市场将快速成长。此外，具有不同遗传背景的快速增长的人口需要量身定制的医疗保健解决方案。此外，意识的提高和支持性法律规范正在推动精准医疗的采用。总而言之，这些动态使该地区成为成长最快的精准医疗市场。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球精准医疗市场：依产品类型

  • 诊断
    • 基因检测
    • 基于生物标记的测试
    • 其他诊断
  • 疗法

第六章全球精准医疗市场：依药物类型

  • Alectinib
  • Aripiprazole月桂酰
  • 美泊利单抗
  • Osimertinib
  • 其他的

第七章全球精准医疗市场：依给药途径

  • 口服
  • 可注射的

第八章 全球精准医疗市场：依定序技术分类

  • 离子半导体序列
  • 奈米孔定序
  • 焦烧序列
  • 连接序列测定
  • 合成定序
  • 其他定序技术

第九章全球精准医疗市场：依技术分类

  • 巨量资料分析
  • 生物资讯学
  • 伴同性诊断
  • 药物研发
  • 基因序列测定
  • 精准分子诊断
  • 其他技术

第十章全球精准医疗市场：依应用分类

  • 中枢神经系统（CNS）
  • 血液学
  • 免疫学
  • 肿瘤学
  • 呼吸系统
  • 其他用途

第十一章全球精准医疗市场：依最终用户分类

  • 资料分析公司
  • 诊断公司和实验室
  • 製药和生物技术公司
  • 调查机构
  • 其他最终用户

第十二章全球精准医疗市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十三章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十四章 公司简介

  • Astarte Medical
  • AstraZeneca PLC
  • Biocrates Life Sciences
  • Biogen
  • Bristol-Myers Squibb
  • Eagle Genomics
  • Labcorp
  • Medtronic PLC
  • Menarini Silicon Biosystems
  • Myriad Genetics Inc.
  • NanoString Technologies
  • Novartis AG
  • Pfizer Inc.
  • Qiagen NV
  • Quest Diagnostics
  • Roche
  • Tepnel Pharma Services
  • Teva Pharmaceutical
  • Thermo Fisher Scientific Inc
Product Code: SMRC24437

According to Stratistics MRC, the Global Precision Medicine Market is accounted for $83.4 billion in 2023 and is expected to reach $202.3 billion by 2030 growing at a CAGR of 13.5% during the forecast period. Precision Medicine customizes healthcare by considering individual variability in genes, environment and lifestyle for disease prevention and treatment. It relies on advanced technologies, like genomic sequencing and data analytics, to tailor medical decisions and therapies to a person's unique characteristics. This approach aims to optimize effectiveness, minimize side effects, and improve overall health outcomes by emphasizing personalized, targeted interventions.

According to WHO, cancer incidence is projected to rise by 50% to reach more than 20 million by the end of this decade.

Market Dynamics:

Driver:

Growing utilization of emerging genomic technologies

The escalating use of emerging genomic technologies propels precision medicine by providing unprecedented insights into an individual's genetic makeup. Next-generation sequencing, CRISPR-based gene editing, and advanced bioinformatics enable comprehensive analysis, identifying genetic variations linked to diseases. This wealth of genomic data facilitates precise diagnosis, prognosis, and personalized treatment strategies, optimizing therapeutic outcomes. Additionally, the growing accessibility and affordability of these technologies further democratize genomic information, making precision medicine more widely applicable.

Restraint:

Elevated expenses associated with therapeutic

Tailored treatments, often relying on advanced technologies and specialized medications, can be prohibitively expensive. This financial burden affects accessibility, limiting widespread adoption of these personalized therapies. Additionally, reimbursement challenges and insurance coverage gaps further hinder patient access.

Opportunity:

Increasing need for cell and gene therapies

The escalating demand for cell and gene therapies presents a significant opportunity in precision medicine. These therapies, often tailored to individual genetic profiles, exemplify the personalized approach of precision medicine. Advances in biotechnology allow for the development of innovative treatments addressing various diseases at the genetic level. As precision medicine evolves, the growing need for customized cell and gene therapies opens avenues for research, development, and market expansion.

Threat:

Strict regulatory standards

Stringent regulations may lengthen the approval process, impeding timely access to innovative treatments. Compliance demands rigorous evidence of efficacy, increasing research and development costs, which could deter smaller firms or startups from entering the market. Additionally, diverse global regulatory landscapes create complexities in standardization and approval across regions, hindering the seamless adoption of precision therapies.

COVID-19 Impact:

The COVID-19 pandemic significantly influenced the precision medicine market by accelerating advancements in technology and research methodologies. It highlighted the critical need for personalized healthcare solutions and underscored the importance of rapid diagnostics, vaccine development, and treatment modalities. Additionally, it spurred collaborations among global scientific communities, fostering innovation and expediting the integration of precision medicine principles into infectious disease management.

The oral segment is expected to be the largest during the forecast period

The oral segment is anticipated to dominate the precision medicine market as it offers convenient and patient-friendly administration of targeted therapies. This mode of delivery enhances patient compliance and allows for personalized treatment plans tailored to individual genetic profiles. The ease of oral medication fosters widespread adoption, facilitating the integration of precision medicine into routine healthcare practices. Additionally, advancements in oral drug formulations and technologies contribute to the segment's leadership, providing healthcare professionals with more options for delivering precise and effective treatments.

The drug discovery segment is expected to have the highest CAGR during the forecast period

The drug discovery segment is estimated to register remarkable growth within the precision medicine market owing to technological strides like AI, genomics, and high-throughput screening. These advancements expedite target identification, validation, and drug development, streamlining the creation of tailored therapies. Precision medicine's focus on individual variations demands a robust pipeline of drugs, propelling investment and innovation in this sector. Additionally, collaborations between biotech, pharmaceutical companies and research institutions foster novel approaches enabling the discovery of highly specific treatments, which positions this segment for sustained expansion.

Region with largest share:

North America is poised to dominate the market, securing the largest share. The region boasts advanced healthcare infrastructure, robust research and development initiatives, and a high prevalence of chronic diseases. Favorable government policies, substantial investments in precision medicine, and a strong presence of key industry players contribute to North America's leadership. Additionally, a well-established regulatory framework and a proactive approach to adopting innovative medical technologies further bolster the region's dominance.

Region with highest CAGR:

The Asia Pacific region is anticipated to witness exponential growth in the precision medicine market owing to rapid advancements in healthcare infrastructure and expanding investments in genomics. Moreover, a burgeoning population with diverse genetic backgrounds necessitates tailored healthcare solutions. Additionally, growing awareness, coupled with supportive regulatory frameworks, propels the adoption of precision medicine. Altogether, these dynamics fuel the region to experience the highest surge in precision medicine market expansion.

Key players in the market:

Some of the key players in Precision Medicine Market include Astarte Medical, AstraZeneca PLC, Biocrates Life Sciences, Biogen, Bristol-Myers Squibb, Eagle Genomics, Labcorp, Medtronic PLC, Menarini Silicon Biosystems, Myriad Genetics Inc., NanoString Technologies, Novartis AG, Pfizer Inc., Qiagen NV, Quest Diagnostics, Roche, Tepnel Pharma Services, Teva Pharmaceutical and Thermo Fisher Scientific Inc.

Key Developments:

In November 2023, Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. and Royalty Pharma plc, announced a collaboration to further accelerate the clinical research program for Teva's olanzapine LAI (TEV-'749) by entering into a funding agreement of up to $125 million to offset program costs. Olanzapine LAI (TEV-'749) is a once-monthly subcutaneous long-acting injection of the atypical antipsychotic olanzapine that is currently in Phase 3 for the treatment of schizophrenia and has the potential to be the first long-acting olanzapine with a favorable safety profile.

In October 2023, Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approval for the Aurora EV-ICD™ MRI SureScan™ (Extravascular Implantable Cardioverter-Defibrillator) and Epsila EV™ MRI SureScan™ defibrillation lead to treat dangerously fast heart rhythms that can lead to sudden cardiac arrest (SCA). The Aurora EV-ICD system is the first-of-its-kind to provide the life-saving benefits of traditional, transvenous ICDs with a lead (thin wire) placed under the breastbone, outside of the heart and veins. The Aurora EV-ICD delivers lifesaving defibrillation, anti-tachycardia pacing (ATP), and back-up (pause-prevention) pacing therapies via a device similar in size, shape, and longevity to traditional, transvenous ICDs.

In October 2023, Labcorp, a global leader of innovative and comprehensive laboratory services, announced it will acquire Baystate Health, Inc.'s (Baystate Health) outreach laboratory business and select operating assets, including laboratory service centers operated by Baystate Health throughout Massachusetts. This strategic relationship will build upon Labcorp's and Baystate Health's existing reference laboratory relationship to improve the efficiency of routine and specialty lab testing.

Product Types Covered:

  • Diagnostics
  • Therapeutics

Drug Types Covered:

  • Alectinib
  • Aripiprazole Lauroxil
  • Mepolizumab
  • Osimertinib
  • Other Drug Types

Route of Administrations Covered:

  • Oral
  • Injectable

Sequencing Technologies Covered:

  • Ion Semiconductor Sequencing
  • Nanopore Sequencing
  • Pyrosequencing
  • Sequencing by Ligation
  • Sequencing by Synthesis
  • Other Sequencing Technologies

Technologies Covered:

  • Big Data Analytics
  • Bioinformatics
  • Companion Diagnostics
  • Drug Discovery
  • Gene Sequencing
  • Precision Molecular Diagnostics
  • Other Technologies

Applications Covered:

  • Central Nervous System (CNS)
  • Hematology
  • Immunology
  • Oncology
  • Respiratory
  • Other Applications

End Users Covered:

  • Data Analytics Companies
  • Diagnostic Companies & Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Precision Medicine Market, By Product Type

  • 5.1 Introduction
  • 5.2 Diagnostics
    • 5.2.1 Genetic Tests
    • 5.2.2 Biomarker Based Tests
    • 5.2.3 Other Diagnostics
  • 5.3 Therapeutics

6 Global Precision Medicine Market, By Drug Type

  • 6.1 Introduction
  • 6.2 Alectinib
  • 6.3 Aripiprazole Lauroxil
  • 6.4 Mepolizumab
  • 6.5 Osimertinib
  • 6.6 Other Drug Types

7 Global Precision Medicine Market, By Route of Administration

  • 7.1 Introduction
  • 7.2 Oral
  • 7.3 Injectable

8 Global Precision Medicine Market, By Sequencing Technology

  • 8.1 Introduction
  • 8.2 Ion Semiconductor Sequencing
  • 8.3 Nanopore Sequencing
  • 8.4 Pyrosequencing
  • 8.5 Sequencing by Ligation
  • 8.6 Sequencing by Synthesis
  • 8.7 Other Sequencing Technologies

9 Global Precision Medicine Market, By Technology

  • 9.1 Introduction
  • 9.2 Big Data Analytics
  • 9.3 Bioinformatics
  • 9.4 Companion Diagnostics
  • 9.5 Drug Discovery
  • 9.6 Gene Sequencing
  • 9.7 Precision Molecular Diagnostics
  • 9.8 Other Technologies

10 Global Precision Medicine Market, By Application

  • 10.1 Introduction
  • 10.2 Central Nervous System (CNS)
  • 10.3 Hematology
  • 10.4 Immunology
  • 10.5 Oncology
  • 10.6 Respiratory
  • 10.7 Other Applications

11 Global Precision Medicine Market, By End User

  • 11.1 Introduction
  • 11.2 Data Analytics Companies
  • 11.3 Diagnostic Companies & Laboratories
  • 11.4 Pharmaceutical & Biotechnology Companies
  • 11.5 Research Institutions
  • 11.6 Other End Users

12 Global Precision Medicine Market, By Geography

  • 12.1 Introduction
  • 12.2 North America
    • 12.2.1 US
    • 12.2.2 Canada
    • 12.2.3 Mexico
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 Italy
    • 12.3.4 France
    • 12.3.5 Spain
    • 12.3.6 Rest of Europe
  • 12.4 Asia Pacific
    • 12.4.1 Japan
    • 12.4.2 China
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 New Zealand
    • 12.4.6 South Korea
    • 12.4.7 Rest of Asia Pacific
  • 12.5 South America
    • 12.5.1 Argentina
    • 12.5.2 Brazil
    • 12.5.3 Chile
    • 12.5.4 Rest of South America
  • 12.6 Middle East & Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 UAE
    • 12.6.3 Qatar
    • 12.6.4 South Africa
    • 12.6.5 Rest of Middle East & Africa

13 Key Developments

  • 13.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 13.2 Acquisitions & Mergers
  • 13.3 New Product Launch
  • 13.4 Expansions
  • 13.5 Other Key Strategies

14 Company Profiling

  • 14.1 Astarte Medical
  • 14.2 AstraZeneca PLC
  • 14.3 Biocrates Life Sciences
  • 14.4 Biogen
  • 14.5 Bristol-Myers Squibb
  • 14.6 Eagle Genomics
  • 14.7 Labcorp
  • 14.8 Medtronic PLC
  • 14.9 Menarini Silicon Biosystems
  • 14.10 Myriad Genetics Inc.
  • 14.11 NanoString Technologies
  • 14.12 Novartis AG
  • 14.13 Pfizer Inc.
  • 14.14 Qiagen NV
  • 14.15 Quest Diagnostics
  • 14.16 Roche
  • 14.17 Tepnel Pharma Services
  • 14.18 Teva Pharmaceutical
  • 14.19 Thermo Fisher Scientific Inc

List of Tables

  • Table 1 Global Precision Medicine Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Precision Medicine Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Precision Medicine Market Outlook, By Diagnostics (2021-2030) ($MN)
  • Table 4 Global Precision Medicine Market Outlook, By Genetic Tests (2021-2030) ($MN)
  • Table 5 Global Precision Medicine Market Outlook, By Biomarker Based Tests (2021-2030) ($MN)
  • Table 6 Global Precision Medicine Market Outlook, By Other Diagnostics (2021-2030) ($MN)
  • Table 7 Global Precision Medicine Market Outlook, By Therapeutics (2021-2030) ($MN)
  • Table 8 Global Precision Medicine Market Outlook, By Drug Type (2021-2030) ($MN)
  • Table 9 Global Precision Medicine Market Outlook, By Alectinib (2021-2030) ($MN)
  • Table 10 Global Precision Medicine Market Outlook, By Aripiprazole Lauroxil (2021-2030) ($MN)
  • Table 11 Global Precision Medicine Market Outlook, By Mepolizumab (2021-2030) ($MN)
  • Table 12 Global Precision Medicine Market Outlook, By Osimertinib (2021-2030) ($MN)
  • Table 13 Global Precision Medicine Market Outlook, By Other Drug Types (2021-2030) ($MN)
  • Table 14 Global Precision Medicine Market Outlook, By Route of Administration (2021-2030) ($MN)
  • Table 15 Global Precision Medicine Market Outlook, By Oral (2021-2030) ($MN)
  • Table 16 Global Precision Medicine Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 17 Global Precision Medicine Market Outlook, By Sequencing Technology (2021-2030) ($MN)
  • Table 18 Global Precision Medicine Market Outlook, By Ion Semiconductor Sequencing (2021-2030) ($MN)
  • Table 19 Global Precision Medicine Market Outlook, By Nanopore Sequencing (2021-2030) ($MN)
  • Table 20 Global Precision Medicine Market Outlook, By Pyrosequencing (2021-2030) ($MN)
  • Table 21 Global Precision Medicine Market Outlook, By Sequencing by Ligation (2021-2030) ($MN)
  • Table 22 Global Precision Medicine Market Outlook, By Sequencing by Synthesis (2021-2030) ($MN)
  • Table 23 Global Precision Medicine Market Outlook, By Other Sequencing Technologies (2021-2030) ($MN)
  • Table 24 Global Precision Medicine Market Outlook, By Technology (2021-2030) ($MN)
  • Table 25 Global Precision Medicine Market Outlook, By Big Data Analytics (2021-2030) ($MN)
  • Table 26 Global Precision Medicine Market Outlook, By Bioinformatics (2021-2030) ($MN)
  • Table 27 Global Precision Medicine Market Outlook, By Companion Diagnostics (2021-2030) ($MN)
  • Table 28 Global Precision Medicine Market Outlook, By Drug Discovery (2021-2030) ($MN)
  • Table 29 Global Precision Medicine Market Outlook, By Gene Sequencing (2021-2030) ($MN)
  • Table 30 Global Precision Medicine Market Outlook, By Precision Molecular Diagnostics (2021-2030) ($MN)
  • Table 31 Global Precision Medicine Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 32 Global Precision Medicine Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 Global Precision Medicine Market Outlook, By Central Nervous System (CNS) (2021-2030) ($MN)
  • Table 34 Global Precision Medicine Market Outlook, By Hematology (2021-2030) ($MN)
  • Table 35 Global Precision Medicine Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 36 Global Precision Medicine Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 37 Global Precision Medicine Market Outlook, By Respiratory (2021-2030) ($MN)
  • Table 38 Global Precision Medicine Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 39 Global Precision Medicine Market Outlook, By End User (2021-2030) ($MN)
  • Table 40 Global Precision Medicine Market Outlook, By Data Analytics Companies (2021-2030) ($MN)
  • Table 41 Global Precision Medicine Market Outlook, By Diagnostic Companies & Laboratories (2021-2030) ($MN)
  • Table 42 Global Precision Medicine Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
  • Table 43 Global Precision Medicine Market Outlook, By Research Institutions (2021-2030) ($MN)
  • Table 44 Global Precision Medicine Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.